4//SEC Filing
Devroe Eric 4
Accession 0000905148-24-001566
CIK 0001781174other
Filed
May 20, 8:00 PM ET
Accepted
May 21, 4:04 PM ET
Size
6.6 KB
Accession
0000905148-24-001566
Insider Transaction Report
Form 4
Devroe Eric
Chief Operating Officer
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2024-05-17−10,000→ 86,615 totalExercise: $1.04Exp: 2031-01-13→ Common Stock (10,000 underlying) - Exercise/Conversion
Common Stock
2024-05-17$1.04/sh+10,000$10,400→ 69,097 total
Footnotes (1)
- [F1]Twenty-five percent (25%) of the shares subject to the option vested on October 5, 2021, and the remaining shares subject to the option vested or shall vest in 12 equal quarterly installments thereafter, in each case subject to the Reporting Person's continuous service through each such vesting date.
Documents
Issuer
Acrivon Therapeutics, Inc.
CIK 0001781174
Entity typeother
Related Parties
1- filerCIK 0001950573
Filing Metadata
- Form type
- 4
- Filed
- May 20, 8:00 PM ET
- Accepted
- May 21, 4:04 PM ET
- Size
- 6.6 KB